Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bridging ED to Outpatient AUD Therapy With Naltrexone

NCT05228418 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bridging ED to Outpatient AUD Therapy With Naltrexone
Lead sponsor
Albert Einstein Healthcare Network
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2022
Completion date
July 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder